Cargando…
Epimutation of MMACHC compound to a genetic mutation in cblC cases
BACKGROUND: Methylmalonic aciduria (MMA) combined with homocystinuria, cobalamin(cbl)C deficiency type (OMIM 277400), is the most common autosomal recessive inherited disorder of intracellular cobalamin metabolism caused by mutations in the MMACHC gene (OMIM 609831), of which more than 100 mutations...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222841/ https://www.ncbi.nlm.nih.gov/pubmed/33982424 http://dx.doi.org/10.1002/mgg3.1625 |
_version_ | 1783711574934945792 |
---|---|
author | Zhang, Xiaoman Chen, Qiong Song, Yinsen Guo, Pengbo Wang, Yanhong Luo, Shuying Zhang, Yaodong Zhou, Chongchen Li, Dongxiao Chen, Yongxing Wei, Haiyan |
author_facet | Zhang, Xiaoman Chen, Qiong Song, Yinsen Guo, Pengbo Wang, Yanhong Luo, Shuying Zhang, Yaodong Zhou, Chongchen Li, Dongxiao Chen, Yongxing Wei, Haiyan |
author_sort | Zhang, Xiaoman |
collection | PubMed |
description | BACKGROUND: Methylmalonic aciduria (MMA) combined with homocystinuria, cobalamin(cbl)C deficiency type (OMIM 277400), is the most common autosomal recessive inherited disorder of intracellular cobalamin metabolism caused by mutations in the MMACHC gene (OMIM 609831), of which more than 100 mutations have been identified to date. In this study, we only identified a coding mutation in one allele at the MMACHC gene locus, and no large fragments deletion or duplication were found. Up to now, only three epimutation cblC cases were reported. We hypothesized whether the MMACHC was hypermethylated. METHODS: To address this hypothesis, the entire coding region and adjacent splice sites of the panel genes involved in metabolic diseases were sequenced using the Illumina HiSeq X platform, followed by confirmation via Sanger sequencing in their parents and brothers. Methylation analysis of the MMACHC was performed using an EpiTect Bisulfite Kit and methylation‐specific PCR (MSP) to investigate the role of epimutations in cblC disease. RESULTS: We identified a clearly pathogenic single heterozygous c.658_660del, p. (K220del) mutation, which was also identified in the mother. Analysis of the MMACHC indicated a heterozygous epimutation consisting of 34 hypermethylated CpG sites in a CpG island encompassing the promoter and first exon of the MMACHC, which was also identified in the father. Furthermore, we identified a single heterozygous c.*2C>T mutation in the sixth exon of the PRDX1 (OMIM 176763) in patients and their fathers, which was the only sequence variation that segregated with the MMACHC methylation. Neither c.658_660del and epimutation in MMACHC nor c.*2C>T in PRDX1 was discovered in her brother. CONCLUSION: We report compound heterozygotes in MMACHC for a genetic mutation and an epimutation in cblC cases. To our best knowledge, this is the first report of two cblC cases from China caused by compound heterozygous mutations with a coding mutation in one allele and an epimutation in the other at the MMACHC locus. |
format | Online Article Text |
id | pubmed-8222841 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82228412021-06-29 Epimutation of MMACHC compound to a genetic mutation in cblC cases Zhang, Xiaoman Chen, Qiong Song, Yinsen Guo, Pengbo Wang, Yanhong Luo, Shuying Zhang, Yaodong Zhou, Chongchen Li, Dongxiao Chen, Yongxing Wei, Haiyan Mol Genet Genomic Med Original Articles BACKGROUND: Methylmalonic aciduria (MMA) combined with homocystinuria, cobalamin(cbl)C deficiency type (OMIM 277400), is the most common autosomal recessive inherited disorder of intracellular cobalamin metabolism caused by mutations in the MMACHC gene (OMIM 609831), of which more than 100 mutations have been identified to date. In this study, we only identified a coding mutation in one allele at the MMACHC gene locus, and no large fragments deletion or duplication were found. Up to now, only three epimutation cblC cases were reported. We hypothesized whether the MMACHC was hypermethylated. METHODS: To address this hypothesis, the entire coding region and adjacent splice sites of the panel genes involved in metabolic diseases were sequenced using the Illumina HiSeq X platform, followed by confirmation via Sanger sequencing in their parents and brothers. Methylation analysis of the MMACHC was performed using an EpiTect Bisulfite Kit and methylation‐specific PCR (MSP) to investigate the role of epimutations in cblC disease. RESULTS: We identified a clearly pathogenic single heterozygous c.658_660del, p. (K220del) mutation, which was also identified in the mother. Analysis of the MMACHC indicated a heterozygous epimutation consisting of 34 hypermethylated CpG sites in a CpG island encompassing the promoter and first exon of the MMACHC, which was also identified in the father. Furthermore, we identified a single heterozygous c.*2C>T mutation in the sixth exon of the PRDX1 (OMIM 176763) in patients and their fathers, which was the only sequence variation that segregated with the MMACHC methylation. Neither c.658_660del and epimutation in MMACHC nor c.*2C>T in PRDX1 was discovered in her brother. CONCLUSION: We report compound heterozygotes in MMACHC for a genetic mutation and an epimutation in cblC cases. To our best knowledge, this is the first report of two cblC cases from China caused by compound heterozygous mutations with a coding mutation in one allele and an epimutation in the other at the MMACHC locus. John Wiley and Sons Inc. 2021-05-12 /pmc/articles/PMC8222841/ /pubmed/33982424 http://dx.doi.org/10.1002/mgg3.1625 Text en © 2021 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Zhang, Xiaoman Chen, Qiong Song, Yinsen Guo, Pengbo Wang, Yanhong Luo, Shuying Zhang, Yaodong Zhou, Chongchen Li, Dongxiao Chen, Yongxing Wei, Haiyan Epimutation of MMACHC compound to a genetic mutation in cblC cases |
title | Epimutation of MMACHC compound to a genetic mutation in cblC cases |
title_full | Epimutation of MMACHC compound to a genetic mutation in cblC cases |
title_fullStr | Epimutation of MMACHC compound to a genetic mutation in cblC cases |
title_full_unstemmed | Epimutation of MMACHC compound to a genetic mutation in cblC cases |
title_short | Epimutation of MMACHC compound to a genetic mutation in cblC cases |
title_sort | epimutation of mmachc compound to a genetic mutation in cblc cases |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222841/ https://www.ncbi.nlm.nih.gov/pubmed/33982424 http://dx.doi.org/10.1002/mgg3.1625 |
work_keys_str_mv | AT zhangxiaoman epimutationofmmachccompoundtoageneticmutationincblccases AT chenqiong epimutationofmmachccompoundtoageneticmutationincblccases AT songyinsen epimutationofmmachccompoundtoageneticmutationincblccases AT guopengbo epimutationofmmachccompoundtoageneticmutationincblccases AT wangyanhong epimutationofmmachccompoundtoageneticmutationincblccases AT luoshuying epimutationofmmachccompoundtoageneticmutationincblccases AT zhangyaodong epimutationofmmachccompoundtoageneticmutationincblccases AT zhouchongchen epimutationofmmachccompoundtoageneticmutationincblccases AT lidongxiao epimutationofmmachccompoundtoageneticmutationincblccases AT chenyongxing epimutationofmmachccompoundtoageneticmutationincblccases AT weihaiyan epimutationofmmachccompoundtoageneticmutationincblccases |